Cellerant Therapeutics Lands $2,094,341 New Financing

  • Feed Type
  • Date
  • Company Name
    Cellerant Therapeutics
  • Mailing Address
    1561 Industrial Road San Carlos, CA 94070
  • Company Description
    Cellerant Therapeutics Inc. is a clinical-stage biotechnology company developing and commercializing the use of hematopoietic (blood-forming) stem cell-based therapies for the treatment of a variety of cancers and autoimmune diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Includes conversion of $1,144,342 of principal and interest from convertible promissory notes. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy